NCT07864207
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07864207
Title Phase 1/2 Multicenter, Open-label, Dose-escalation Study of IDP- 121 in Patients With Platinum-resistant Small Cell Lung Cancer (MYCrocytic) (MYCrocytic)
Acronym MYCrocytic
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors IDP Discovery Pharma S.L.
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital del Mar NOT_YET_RECRUITING Barcelona Spain Details
ICO Badalona Germans trias i Pujol NOT_YET_RECRUITING Barcelona Spain Details
Hospital Universitario Gran Canaria NOT_YET_RECRUITING Las Palmas de Gran Canaria Spain Details
Clinica Universidad de Navarra (CUN) RECRUITING Madrid Spain Details
Hospital Regional Universitario de Málaga RECRUITING Málaga Spain Details
Hospital Universitario Virgen de la Arrixaca RECRUITING Murcia Spain Details
Clinica Universidad de Navarra (CUN) RECRUITING Pamplona Spain Details
Hospital Universitario de Navarra RECRUITING Pamplona Spain Details
Hospital Universitario Nstra Señora de Candelaria NOT_YET_RECRUITING Santa Cruz de Tenerife Spain Details
Hospital Clínico de Valencia RECRUITING Valencia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field